{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:37:11Z","timestamp":1793763431618,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T00:00:00Z","timestamp":1532736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["2008 04 POL \u2013 193340 \u2013 CFBA \u2013 56916"],"award-info":[{"award-number":["2008 04 POL \u2013 193340 \u2013 CFBA \u2013 56916"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["NCT01694329"],"award-info":[{"award-number":["NCT01694329"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.vaccine.2018.07.008","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T12:03:53Z","timestamp":1531829033000},"page":"5180-5186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence of middle ear abnormalities from otitis media in relation with pneumococcal vaccine use in the Inuit population of Nunavik, province of Quebec, Canada"],"prefix":"10.1016","volume":"36","author":[{"given":"J.B.","family":"Le Meur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ayukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Proulx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"De Wals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.07.008_b0005","first-page":"1569","article-title":"Aboriginal health","volume":"155","author":"MacMillan","year":"1996","journal-title":"CAMJ"},{"issue":"4","key":"10.1016\/j.vaccine.2018.07.008_b0010","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/25761900.2022.12220643","article-title":"Longitudinal observations (1987\u20131997) on the prevalence of middle ear disease and associated risk factors among Inuit children of Inukjuak, Nunavik, Qu\u00e9bec, Canada","volume":"60","author":"Bruneau","year":"2001","journal-title":"Int J Circumpolar Health"},{"key":"10.1016\/j.vaccine.2018.07.008_b0015","series-title":"Health and what affects it in Nunavik: how is the situation changing?","author":"Hodgins","year":"1997"},{"issue":"4","key":"10.1016\/j.vaccine.2018.07.008_b0020","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.17269\/cjph.105.4315","article-title":"Uptake of pneumococcal vaccines in the Nordic region of Nunavik, province of Quebec, Canada","volume":"105","author":"Cl\u00e9ophat","year":"2014","journal-title":"Can J Public Health"},{"key":"10.1016\/j.vaccine.2018.07.008_b0025","series-title":"Elaboration of a classification and score system for audiology screening data in Inuit children of Nunavik. Master\u2019s thesis","author":"Boisvert","year":"2004"},{"issue":"3","key":"10.1016\/j.vaccine.2018.07.008_b0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2018.07.008_b0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.07.008_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001657","article-title":"Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial","volume":"11","author":"Tregnaghi","year":"2014","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.vaccine.2018.07.008_b0045","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1473-3099(15)00549-6","article-title":"Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease","volume":"16","author":"Dagan","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.008_b0050","article-title":"Early vaccine-type pneumococcal aAcute otitis media does not predispose to subsequent otitis when compared to early acute otitis media due to other bacterial etiology","author":"Palmu","year":"2017","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.008_b0055","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/21645515.2015.1118593","article-title":"Interim results of an ecological experiment \u2013 conjugate vaccination against the pneumococcus and serotype replacement","volume":"12","author":"Hausdorff","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2018.07.008_b0060","first-page":"S1","article-title":"Classification and criteria of otitis media","volume":"3","author":"Berman","year":"1997","journal-title":"Clin Microbiol Infect."},{"issue":"4","key":"10.1016\/j.vaccine.2018.07.008_b0065","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/00325481.2015.1028872","article-title":"Acute otitis media","volume":"127","author":"Atkinson","year":"2015","journal-title":"Postgrad Med"},{"issue":"4","key":"10.1016\/j.vaccine.2018.07.008_b0070","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/00325481.2015.1028317","article-title":"Otitis media with effusion","volume":"127","author":"Atkinson","year":"2015","journal-title":"Postgrad Med"},{"issue":"4","key":"10.1016\/j.vaccine.2018.07.008_b0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/00325481.2015.1027133","article-title":"Chronic otitis media","volume":"127","author":"Wallis","year":"2015","journal-title":"Postgrad Med"},{"issue":"4","key":"10.1016\/j.vaccine.2018.07.008_b0080","first-page":"CD001480","article-title":"Pneumococcal conjugate vaccines for preventing otitis media","volume":"2","author":"Fortanier","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2018.07.008_b0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jpids\/piw010","article-title":"Effectiveness of the 10-Valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugated vaccine (PHiD-CV) against carriage and acute otitis media-A double-blind randomized clinical trial in Finland","volume":"5","author":"Vesikari","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2018.07.008_b0090","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/ciu683","article-title":"Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent\/13-valent PCV","volume":"59","author":"Ben-Shimol","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.008_b0095","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/INF.0000000000001704","article-title":"Trends in otitis media and myringotomy with tube placement among American indian and Alaska native children and the US general population of children after introduction of the 13-valent pneumococcal conjugate vaccine","volume":"37","author":"Singleton","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2018.07.008_b0100","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/INF.0000000000001654","article-title":"Trends in otitis media incidence after conjugate pneumococcal vaccination: a national observational study","volume":"36","author":"Gisselsson-Solen","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.07.008_b0105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1471-2431-14-200","article-title":"Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules","volume":"14","author":"Leach","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.vaccine.2018.07.008_b0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12887-015-0483-8","article-title":"Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine","volume":"15","author":"Leach","year":"2015","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.vaccine.2018.07.008_b0115","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijporl.2016.05.011","article-title":"General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines","volume":"86","author":"Leach","year":"2016","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"9376","key":"10.1016\/j.vaccine.2018.07.008_b0120","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0140-6736(03)13772-5","article-title":"Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study","volume":"361","author":"Veenhoven","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.07.008_b0125","unstructured":"Canadian Paediatric Society, Infectious Diseases and Immunization Committee [Principal author: D Speert]. Antibiotic management of acute otitis media Paediatr Child Health 1998; 3(4): 265\u20137."},{"issue":"7","key":"10.1016\/j.vaccine.2018.07.008_b0130","first-page":"457","article-title":"Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Management of acute otitis media","volume":"14","author":"Forgie","year":"2009","journal-title":"Paediatr Child Health"},{"issue":"1","key":"10.1016\/j.vaccine.2018.07.008_b0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/pch\/21.1.39","article-title":"Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Management of acute otitis media in children six months of age and older","volume":"21","author":"Le Saux","year":"2016","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2018.07.008_b0140","unstructured":"Ungava Tullatavik Health Centre: OMA treatment guideline. 1989-2003."},{"key":"10.1016\/j.vaccine.2018.07.008_b0145","unstructured":"Innulitsivik Health Centre: OMA treatment guideline. 1991-2005."},{"key":"10.1016\/j.vaccine.2018.07.008_b0150","first-page":"139","article-title":"Effectiveness of tympanostomy tubes for otitis media: a meta-analysis","author":"Steele","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2018.07.008_b0155","first-page":"CD010089","article-title":"Influenza vaccines for preventing acute otitis media in infants and children","volume":"10","author":"Norhayati","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2018.07.008_b0160","unstructured":"Protocole d\u2019immunisation du Qu\u00e9bec. \u00c9dition 6. Minist\u00e8re de la Sant\u00e9 et des Services sociaux du Qu\u00e9bec. Qu\u00e9bec City (QC), Canada, 2017. Available at: <http:\/\/publications.msss.gouv.qc.ca\/msss\/document-000105\/> Last access: 2017-03-05."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18309381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18309381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:27:44Z","timestamp":1759400864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18309381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":32,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0264410X18309381"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of middle ear abnormalities from otitis media in relation with pneumococcal vaccine use in the Inuit population of Nunavik, province of Quebec, Canada","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}